Marksans Pharma to sell Active Pharmaceutical Ingredient (API) business to KORES (India) - MarketLine Financial Deals

Marksans Pharma to sell Active Pharmaceutical Ingredient (API) business to KORES (India)

Marksans Pharma to sell Active Pharmaceutical Ingredient (API) business to KORES (India) - MarketLine Financial Deals
Marksans Pharma to sell Active Pharmaceutical Ingredient (API) business to KORES (India)
Published Feb 02, 2010
2 pages — Published Feb 02, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Marksans Pharma, Ltd., an India-based manufacturer of formulations and active pharmaceutical ingredients, has entered into a business transfer agreement to sell its Active Pharmaceutical Ingredient (API) business together with the manufacturing facilities located in Kurkumbh, Pune in Maharashtra, India, to KORES (India), Ltd., a stationery products company.

  
Source:
Document ID
MA30434_100812
Country
Ticker
524404=IN
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Marksans Pharma to sell Active Pharmaceutical Ingredient (API) business to KORES (India)" Feb 02, 2010. Alacra Store. Dec 08, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Marksans-Pharma-to-sell-Active-Pharmaceutical-Ingredient-API-business-to-KORES-India-2052-38674>
  
APA:
MarketLine Financial Deals. (2010). Marksans Pharma to sell Active Pharmaceutical Ingredient (API) business to KORES (India) Feb 02, 2010. New York, NY: Alacra Store. Retrieved Dec 08, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Marksans-Pharma-to-sell-Active-Pharmaceutical-Ingredient-API-business-to-KORES-India-2052-38674>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.